British Society of Gastroenterology, British Association for the Study of the Liver and Society for Acute Medicine
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
Consensus statement · Tier 2, Specialist societies · UK · 2025-04-18
Current — checked with the publisher on 2026-09-01
DOI 10.1136/flgastro-2025-103074
https://www.bsg.org.uk/clinical-resource/new-decompensated-cirrhosis-admission-care-bundle
What this platform has drawn from it — 1 claim
- The BSG/BASL 2025 decompensated cirrhosis admission care bundle recommends a restrictive red cell transfusion target of 70-80 g/L in haemodynamically stable patients with upper gastrointestinal bleeding, graded as high quality of evidence, and states that in haemodynamic instability the strategy depends on the clinical scenario.
Table 1, red cell transfusion row, quality of evidence 'High', audit standard 90% · Body, section 'Transfusion: red blood cells', sentence following the recommendation
read on Variceal bleeding
How this record was checked, and what is doubtful about it
Updates the 2014 original bundle. Covers the first 24 hours of admission. Assessment domains: precipitating factors, infection, ascites, acute kidney injury, hepatic encephalopathy. GRADE-assessed. Primary UK anchor for the First 24 Hours pathway.
Verification: verified · last accessed 2026-09-01 · status checked against https://www.bsg.org.uk/clinical-resource/new-decompensated-cirrhosis-admission-care-bundle